SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-057852
Filing Date
2018-09-20
Accepted
2018-09-20 18:00:12
Documents
1
Period of Report
2018-09-20

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1428
  Complete submission text file 0001104659-18-057852.txt   2783
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HBM PARTNERS AG BUNDESPLATZ 1 6300 ZUG V8 6300 ZUG
Business Address
Buschle Michael (Reporting) CIK: 0001753357 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38650 | Film No.: 181080213